Published in Circ Res on February 21, 2003
Cardiotoxicity of anticancer treatments: what the cardiologist needs to know. Nat Rev Cardiol (2010) 1.80
Metabolic syndrome: the danger signal in atherosclerosis. Vasc Health Risk Manag (2006) 1.13
High density lipoproteins and endothelial functions: mechanistic insights and alterations in cardiovascular disease. J Lipid Res (2013) 1.09
Selective delipidation of plasma HDL enhances reverse cholesterol transport in vivo. J Lipid Res (2009) 1.08
High-density lipoprotein determines adult mouse cardiomyocyte fate after hypoxia-reoxygenation through lipoprotein-associated sphingosine 1-phosphate. Am J Physiol Heart Circ Physiol (2010) 1.07
HDL and its sphingosine-1-phosphate content in cardioprotection. Heart Fail Rev (2007) 0.97
The Emerging Role of TLR and Innate Immunity in Cardiovascular Disease. Cardiol Res Pract (2012) 0.95
Corticosteroids induce COX-2 expression in cardiomyocytes: role of glucocorticoid receptor and C/EBP-beta. Am J Physiol Cell Physiol (2008) 0.89
Ability of a biomarker-based score to predict death from circulatory disease and cancer in NHANES III. BMC Public Health (2012) 0.83
HDL and glucose metabolism: current evidence and therapeutic potential. Front Pharmacol (2015) 0.83
Tweaking the cholesterol efflux capacity of reconstituted HDL. Biochem Cell Biol (2012) 0.82
High density lipoprotein/sphingosine-1-phosphate-induced cardioprotection: Role of STAT3 as part of the SAFE pathway. JAKSTAT (2012) 0.82
Apolipoproteins inhibit the innate immunity activated by necrotic cells or bacterial endotoxin. Immunology (2008) 0.81
Improving reconstituted HDL composition for efficient post-ischemic reduction of ischemia reperfusion injury. PLoS One (2015) 0.81
Serum lipid profiles and cancer risk in the context of obesity: four meta-analyses. J Cancer Epidemiol (2013) 0.81
Prostaglandin E Receptor Subtype 4 Signaling in the Heart: Role in Ischemia/Reperfusion Injury and Cardiac Hypertrophy. J Diabetes Res (2016) 0.80
Protective Effects of HDL Against Ischemia/Reperfusion Injury. Front Pharmacol (2016) 0.80
Cardioprotection with high-density lipoproteins: fact or fiction? Circ Res (2003) 0.80
Tumour necrosis factor-α promotes liver ischaemia-reperfusion injury through the PGC-1α/Mfn2 pathway. J Cell Mol Med (2014) 0.80
LY294002 inhibits glucocorticoid-induced COX-2 gene expression in cardiomyocytes through a phosphatidylinositol 3 kinase-independent mechanism. Toxicol Appl Pharmacol (2008) 0.79
RISK and SAFE signaling pathway involvement in apolipoprotein A-I-induced cardioprotection. PLoS One (2014) 0.79
Intravenous sphingosylphosphorylcholine protects ischemic and postischemic myocardial tissue in a mouse model of myocardial ischemia/reperfusion injury. Mediators Inflamm (2011) 0.77
ApoA-I induced CD31 in bone marrow-derived vascular progenitor cells increases adhesion: implications for vascular repair. Biochim Biophys Acta (2008) 0.76
Harnessing the early post-injury inflammatory responses for cardiac regeneration. J Biomed Sci (2017) 0.75
The Effect of Lipopolysaccharide on Ischemic-Reperfusion Injury of Heart: A Double Hit Model of Myocardial Ischemia and Endotoxemia. J Cardiovasc Thorac Res (2015) 0.75
Reconstituted high-density lipoprotein modulates activation of human leukocytes. PLoS One (2013) 0.75
Activity exerted by a testosterone derivative on myocardial injury using an ischemia/reperfusion model. Biomed Res Int (2014) 0.75
Analysis of Serum Cholesterol Efflux Capacity in a Minipig Model of Nonischemic Heart Failure. J Atheroscler Thromb (2016) 0.75
Anti-inflammatory and gastrointestinal effects of a novel diclofenac derivative. Free Radic Biol Med (2006) 1.81
Mesenchymal stromal cells primed with paclitaxel provide a new approach for cancer therapy. PLoS One (2011) 1.58
Functional lecithin: cholesterol acyltransferase is not required for efficient atheroprotection in humans. Circulation (2009) 1.56
Angiotensin II type 1 receptor antagonism improves endothelial vasodilator function in L-NAME-induced hypertensive rats by a kinin-dependent mechanism. J Hypertens (2006) 1.50
Role of LCAT in HDL remodeling: investigation of LCAT deficiency states. J Lipid Res (2006) 1.47
Enzymatically active paraoxonase-1 is located at the external membrane of producing cells and released by a high affinity, saturable, desorption mechanism. J Biol Chem (2001) 1.39
Endothelial protection by high-density lipoproteins: from bench to bedside. Arterioscler Thromb Vasc Biol (2003) 1.28
Recombinant apolipoprotein A-I(Milano) infusion into rabbit carotid artery rapidly removes lipid from fatty streaks. Circ Res (2002) 1.22
Structure, function and amyloidogenic propensity of apolipoprotein A-I. Amyloid (2006) 1.22
The molecular basis of lecithin:cholesterol acyltransferase deficiency syndromes: a comprehensive study of molecular and biochemical findings in 13 unrelated Italian families. Arterioscler Thromb Vasc Biol (2005) 1.19
Genetic lecithin:cholesterol acyltransferase deficiency and cardiovascular disease. Atherosclerosis (2011) 1.17
Depletion of pre-beta-high density lipoprotein by human chymase impairs ATP-binding cassette transporter A1- but not scavenger receptor class B type I-mediated lipid efflux to high density lipoprotein. J Biol Chem (2003) 1.17
Small discoidal pre-beta1 HDL particles are efficient acceptors of cell cholesterol via ABCA1 and ABCG1. Biochemistry (2009) 1.07
An omega-3 polyunsaturated fatty acid concentrate increases plasma high-density lipoprotein 2 cholesterol and paraoxonase levels in patients with familial combined hyperlipidemia. Metabolism (2004) 1.05
Lecithin:cholesterol acyltransferase, high-density lipoproteins, and atheroprotection in humans. Trends Cardiovasc Med (2010) 1.03
Macrophage, but not systemic, apolipoprotein E is necessary for macrophage reverse cholesterol transport in vivo. Arterioscler Thromb Vasc Biol (2010) 1.02
The LXR agonist T0901317 promotes the reverse cholesterol transport from macrophages by increasing plasma efflux potential. J Lipid Res (2008) 0.99
Characterization of three kindreds with familial combined hypolipidemia caused by loss-of-function mutations of ANGPTL3. Circ Cardiovasc Genet (2011) 0.99
Effect of hydrogen sulphide-donating sildenafil (ACS6) on erectile function and oxidative stress in rabbit isolated corpus cavernosum and in hypertensive rats. BJU Int (2009) 0.98
Procyanidins from grape seeds protect endothelial cells from peroxynitrite damage and enhance endothelium-dependent relaxation in human artery: new evidences for cardio-protection. Life Sci (2003) 0.96
Enalapril and quinapril improve endothelial vasodilator function and aortic eNOS gene expression in L-NAME-treated rats. Eur J Pharmacol (2002) 0.95
The carbonyl scavenger carnosine ameliorates dyslipidaemia and renal function in Zucker obese rats. J Cell Mol Med (2010) 0.95
Anti-inflammatory and cardioprotective activities of synthetic high-density lipoprotein containing apolipoprotein A-I mimetic peptides. J Pharmacol Exp Ther (2007) 0.95
A unique protease-sensitive high density lipoprotein particle containing the apolipoprotein A-I(Milano) dimer effectively promotes ATP-binding Cassette A1-mediated cell cholesterol efflux. J Biol Chem (2006) 0.94
Pharmacological profile of a novel H(2)S-releasing aspirin. Free Radic Biol Med (2008) 0.94
Synthesis, selective anti-Helicobacter pylori activity, and cytotoxicity of novel N-substituted-2-oxo-2H-1-benzopyran-3-carboxamides. Bioorg Med Chem Lett (2010) 0.93
Functional LCAT is not required for macrophage cholesterol efflux to human serum. Atherosclerosis (2008) 0.91
Normal vascular function despite low levels of high-density lipoprotein cholesterol in carriers of the apolipoprotein A-I(Milano) mutant. Circulation (2007) 0.90
Elevated soluble cellular adhesion molecules in subjects with low HDL-cholesterol. Arterioscler Thromb Vasc Biol (2002) 0.90
Differential effects of fenofibrate and extended-release niacin on high-density lipoprotein particle size distribution and cholesterol efflux capacity in dyslipidemic patients. J Clin Lipidol (2013) 0.90
Mast cell chymase degrades apoE and apoA-II in apoA-I-knockout mouse plasma and reduces its ability to promote cellular cholesterol efflux. Arterioscler Thromb Vasc Biol (2002) 0.89
Activity of a new hydrogen sulfide-releasing aspirin (ACS14) on pathological cardiovascular alterations induced by glutathione depletion in rats. Eur J Pharmacol (2010) 0.89
Severe high-density lipoprotein deficiency associated with autoantibodies against lecithin:cholesterol acyltransferase in non-Hodgkin lymphoma. Arch Intern Med (2012) 0.88
Synthesis of human renalase1 in Escherichia coli and its purification as a FAD-containing holoprotein. Protein Expr Purif (2010) 0.88
Apolipoprotein A-IMilano/POPC complex attenuates post-ischemic ventricular dysfunction in the isolated rabbit heart. Atherosclerosis (2007) 0.87
Recombinant apolipoprotein A-IMilano for the treatment of cardiovascular diseases. Curr Atheroscler Rep (2006) 0.87
The water-soluble vitamin E analogue Trolox protects against ischaemia/reperfusion damage in vitro and ex vivo. A comparison with vitamin E. Pharmacol Res (2002) 0.86
Synthetic high density lipoproteins for the treatment of myocardial ischemia/reperfusion injury. Pharmacol Ther (2006) 0.86
Synthetic high-density lipoproteins exert cardioprotective effects in myocardial ischemia/reperfusion injury. J Pharmacol Exp Ther (2003) 0.85
Nitric oxide and prostacyclin pathways: an integrated mechanism that limits myocardial infarction progression in anaesthetized rats. Pharmacol Res (2006) 0.85
Mesenchymal stromal cells primed with Paclitaxel attract and kill leukaemia cells, inhibit angiogenesis and improve survival of leukaemia-bearing mice. Br J Haematol (2013) 0.84
Nitric oxide release and distribution following oral and intraperitoneal administration of nitroaspirin (NCX 4016) in the rat. Life Sci (2004) 0.84
Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats. Eur J Pharmacol (2005) 0.84
Positive interaction of the novel beta2-agonist carmoterol and tiotropium bromide in the control of airway changes induced by different challenges in guinea-pigs. Pulm Pharmacol Ther (2006) 0.84
The C-terminal domain of apolipoprotein A-I is involved in ABCA1-driven phospholipid and cholesterol efflux. Biochem Biophys Res Commun (2002) 0.83
Asymmetric dimethylarginine (ADMA) induces vascular endothelium impairment and aggravates post-ischemic ventricular dysfunction in rats. Eur J Pharmacol (2006) 0.83
Plasma lecithin:cholesterol acyltransferase and carotid intima-media thickness in European individuals at high cardiovascular risk. J Lipid Res (2011) 0.83
Effects of established hypolipidemic drugs on HDL concentration, subclass distribution, and function. Handb Exp Pharmacol (2015) 0.83
The nitric oxide-releasing naproxen derivative displays cardioprotection in perfused rabbit heart submitted to ischemia-reperfusion. J Pharmacol Exp Ther (2004) 0.83
Novel mutations of CETP gene in Italian subjects with hyperalphalipoproteinemia. Atherosclerosis (2008) 0.82
High-density lipoprotein quantity or quality for cardiovascular prevention? Curr Pharm Des (2010) 0.82
Effect of the amyloidogenic L75P apolipoprotein A-I variant on HDL subpopulations. Clin Chim Acta (2011) 0.82
Human skin-derived fibroblasts acquire in vitro anti-tumor potential after priming with Paclitaxel. Anticancer Agents Med Chem (2013) 0.82
Synthetic HDL as a new treatment for atherosclerosis regression: has the time come? Nutr Metab Cardiovasc Dis (2008) 0.82
Hypocholesterolaemic effects of lupin protein and pea protein/fibre combinations in moderately hypercholesterolaemic individuals. Br J Nutr (2011) 0.82
Recombinant human LCAT normalizes plasma lipoprotein profile in LCAT deficiency. Biologicals (2013) 0.82
Apolipoprotein composition and particle size affect HDL degradation by chymase: effect on cellular cholesterol efflux. J Lipid Res (2002) 0.82
Structure and function of the apoA-IV T347S and Q360H common variants. Biochem Biophys Res Commun (2010) 0.81
A mesenchymal stromal cell line resistant to paclitaxel that spontaneously differentiates into osteoblast-like cells. Cell Biol Toxicol (2010) 0.81
A novel homozygous mutation in CETP gene as a cause of CETP deficiency in a Caucasian kindred. Atherosclerosis (2009) 0.81
Effect of repeated apoA-IMilano/POPC infusion on lipids, (apo)lipoproteins, and serum cholesterol efflux capacity in cynomolgus monkeys. J Lipid Res (2013) 0.81
Methylprednisolone-loaded PLGA microspheres: a new formulation for sustained release via intra-articular administration. A comparison study with methylprednisolone acetate in rats. J Pharm Sci (2011) 0.81
Positive interaction of the beta2-agonist CHF 4226.01 with budesonide in the control of bronchoconstriction induced by acetaldehyde in the guinea-pigs. Br J Pharmacol (2005) 0.80
Increased carotid artery intima-media thickness in subjects with primary hypoalphalipoproteinemia. Arterioscler Thromb Vasc Biol (2002) 0.80
Inflammation impairs eNOS activation by HDL in patients with acute coronary syndrome. Cardiovasc Res (2013) 0.80
A 33-year-old man with nephrotic syndrome and lecithin-cholesterol acyltransferase (LCAT) deficiency. Description of two new mutations in the LCAT gene. Nephrol Dial Transplant (2004) 0.80
Formoterol and beclomethasone dipropionate interact positively in antagonising bronchoconstriction and inflammation in the lung. Pharmacol Res (2007) 0.79
A model structure for the heterodimer apoA-IMilano-apoA-II supports its peculiar susceptibility to proteolysis. Biophys J (2006) 0.79
Design, synthesis, ADME properties, and pharmacological activities of β-alanyl-D-histidine (D-carnosine) prodrugs with improved bioavailability. ChemMedChem (2011) 0.79
Ellagitannins from Rubus berries for the control of gastric inflammation: in vitro and in vivo studies. PLoS One (2013) 0.79
Plasma cardiac necrosis markers C-troponin I and creatine kinase, associated with increased malondialdehyde levels, induced in rabbits by means of 5-aminolevulinic acid injection. Pharmacology (2009) 0.79
Apolipoprotein A-I breakdown is induced by thrombolysis in coronary patients. Ann Med (2007) 0.79
Anti-ischemic activity and endothelium-dependent vasorelaxant effect of hydrolysable tannins from the leaves of Rhus coriaria (Sumac) in isolated rabbit heart and thoracic aorta. Planta Med (2009) 0.79
Inhibition of MMP-2 activation and release as a novel mechanism for HDL-induced cardioprotection. FEBS Lett (2006) 0.79
GH-related and extra-endocrine actions of GH secretagogues in aging. Neurobiol Aging (2002) 0.79
Ghrelin plays a minor role in the physiological control of cardiac function in the rat. Endocrinology (2003) 0.79